Yeah, that's also how I have been surviving the "Third-Tier from Hell" days..... with trading positions in my favorite companies, and by effectively trading news (dried up about two months ago).
Like you, perhaps, my trading position is usually large in comparison to my hold position. However, with SIBI, it's exactly the opposite...... I have a large "hold" position which has now been rotting for about thirty seven years, and I've been trading SIBI for peanuts.
One other point..... I don't often have more than a couple trading positions out at once...... I can't afford to do such, both from a concentration stance and from a resources one.
This is a good time to reinforce an old thought..... the upcoming 1508 (thanks, Rudy) results??..... I haven't a clue. I believe that the scientific infrastructure at SIBI is (and has been) good, and that the company is fundamentally undervalued. But, I have virtually no neurologist in me, no relevant experience.
and, again..... I did not expect to arrive at this point without a partner for VGCC/pain, and I did not expect to have this much downside risk associated with phase II results. As for all biotechs, if conservation of capital is your primary investment principle (funny how daytraders share that trait with the most conservative of investors), you're tuned to the wrong thread. |
